Literature DB >> 33469705

MACC1 regulates clathrin-mediated endocytosis and receptor recycling of transferrin receptor and EGFR in colorectal cancer.

Francesca Imbastari1, Mathias Dahlmann2,3, Anje Sporbert4, Camilla Ciolli Mattioli5, Tommaso Mari6, Florian Scholz7, Lena Timm1, Shailey Twamley1, Rebekka Migotti8, Wolfgang Walther1,9, Gunnar Dittmar10, Armin Rehm7, Ulrike Stein11,12.   

Abstract

Metastasis Associated in Colon Cancer 1 (MACC1) is a novel prognostic, predictive and causal biomarker for tumor progression and metastasis in many cancer types, including colorectal cancer. Besides its clinical value, little is known about its molecular function. Its similarity to SH3BP4, involved in regulating uptake and recycling of transmembrane receptors, suggests a role of MACC1 in endocytosis. By exploring the MACC1 interactome, we identified the clathrin-mediated endocytosis (CME)-associated proteins CLTC, DNM2 and AP-2 as MACC1 binding partners. We unveiled a MACC1-dependent routing of internalized transferrin receptor towards recycling. Elevated MACC1 expression caused also the activation and internalization of EGFR, a higher rate of receptor recycling, as well as earlier and stronger receptor activation and downstream signaling. These effects are limited by deletion of CME-related protein interaction sites in MACC1. Thus, MACC1 regulates CME and receptor recycling, causing increased growth factor-mediated downstream signaling and cell proliferation. This novel mechanism unveils potential therapeutic intervention points restricting MACC1-driven metastasis.

Entities:  

Keywords:  CME; Colorectal cancer; EGFR; MACC1; Receptor recycling; Transferrin receptor

Mesh:

Substances:

Year:  2021        PMID: 33469705     DOI: 10.1007/s00018-020-03734-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  46 in total

1.  TTP specifically regulates the internalization of the transferrin receptor.

Authors:  Daniela Tosoni; Claudia Puri; Stefano Confalonieri; Anna Elisabetta Salcini; Pietro De Camilli; Carlo Tacchetti; Pier Paolo Di Fiore
Journal:  Cell       Date:  2005-12-02       Impact factor: 41.582

2.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification.

Authors:  Jürgen Cox; Matthias Mann
Journal:  Nat Biotechnol       Date:  2008-11-30       Impact factor: 54.908

3.  Functional proteomics defines the molecular switch underlying FGF receptor trafficking and cellular outputs.

Authors:  Chiara Francavilla; Kristoffer T G Rigbolt; Kristina B Emdal; Gianni Carraro; Erik Vernet; Dorte B Bekker-Jensen; Werner Streicher; Mats Wikström; Michael Sundström; Saverio Bellusci; Ugo Cavallaro; Blagoy Blagoev; Jesper V Olsen
Journal:  Mol Cell       Date:  2013-09-05       Impact factor: 17.970

4.  MACC1 Induces Tumor Progression in Transgenic Mice and Colorectal Cancer Patients via Increased Pluripotency Markers Nanog and Oct4.

Authors:  Clara Lemos; Markus S Hardt; Manisha Juneja; Cynthia Voss; Susann Förster; Boris Jerchow; Wolfram Haider; Hendrik Bläker; Ulrike Stein
Journal:  Clin Cancer Res       Date:  2016-01-12       Impact factor: 12.531

Review 5.  Colorectal Cancer Chemotherapy: The Evolution of Treatment and New Approaches.

Authors:  Rachel M McQuade; Vanesa Stojanovska; Joel C Bornstein; Kulmira Nurgali
Journal:  Curr Med Chem       Date:  2017       Impact factor: 4.530

6.  Downregulation of MACC1 inhibits invasion, migration and proliferation, attenuates cisplatin resistance and induces apoptosis in tongue squamous cell carcinoma.

Authors:  Hai-Feng Li; Ye-Qing Liu; Zhuo-Jian Shen; Xiang-Feng Gan; Jing-Jing Han; Yun-Yun Liu; Hai-Gang Li; Zhi-Quan Huang
Journal:  Oncol Rep       Date:  2014-11-21       Impact factor: 3.906

Review 7.  MACC1-the first decade of a key metastasis molecule from gene discovery to clinical translation.

Authors:  Harikrishnan Radhakrishnan; Wolfgang Walther; Fabian Zincke; Dennis Kobelt; Francesca Imbastari; Müge Erdem; Benedikt Kortüm; Mathias Dahlmann; Ulrike Stein
Journal:  Cancer Metastasis Rev       Date:  2018-12       Impact factor: 9.264

Review 8.  MACC1 - more than metastasis? Facts and predictions about a novel gene.

Authors:  Ulrike Stein; Mathias Dahlmann; Wolfgang Walther
Journal:  J Mol Med (Berl)       Date:  2009-09-30       Impact factor: 4.599

9.  MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis.

Authors:  Ulrike Stein; Wolfgang Walther; Franziska Arlt; Holger Schwabe; Janice Smith; Iduna Fichtner; Walter Birchmeier; Peter M Schlag
Journal:  Nat Med       Date:  2008-12-21       Impact factor: 53.440

10.  Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips.

Authors:  Juri Rappsilber; Matthias Mann; Yasushi Ishihama
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

View more
  4 in total

1.  Exploration of the Proteomic Landscape of Small Extracellular Vesicles in Serum as Biomarkers for Early Detection of Colorectal Neoplasia.

Authors:  Li-Chun Chang; Yi-Chiung Hsu; Han-Mo Chiu; Koji Ueda; Ming-Shiang Wu; Chiun-How Kao; Tang-Long Shen
Journal:  Front Oncol       Date:  2021-09-13       Impact factor: 6.244

2.  The Relationship between MACC1/c-Met/Cyclin D1 Axis Expression and Prognosis in ESCC.

Authors:  Yan Shi; Meng-Yan Li; Hui Wang; Chao Li; Wen-Ying Liu; Yong-Mei Gao; Bo Wang; Jia-Wei Song; Yu-Qing Ma
Journal:  Anal Cell Pathol (Amst)       Date:  2022-02-22       Impact factor: 2.916

3.  Calcium-binding protein S100P is a new target gene of MACC1, drives colorectal cancer metastasis and serves as a prognostic biomarker.

Authors:  Felicitas Schmid; Mathias Dahlmann; Hanna Röhrich; Dennis Kobelt; Jens Hoffmann; Susen Burock; Wolfgang Walther; Ulrike Stein
Journal:  Br J Cancer       Date:  2022-05-21       Impact factor: 9.075

4.  LncRNA FGD5-AS1 Facilitates the Radioresistance of Breast Cancer Cells by Enhancing MACC1 Expression Through Competitively Sponging miR-497-5p.

Authors:  Ji Li; Changjiang Lei; Bineng Chen; Qingfang Zhu
Journal:  Front Oncol       Date:  2021-06-18       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.